Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price comments

Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to cut the cost of brand name GLP-1 weight loss drugs to $150…

Obesity pills from Eli Lilly, Novo Nordisk near US launch

Eli Lilly and Novo Nordisk are preparing to take their rivalry to the next frontier of weight-loss medications: pills. Both companies expect to launch oral obesity drugs in the U.S.…